Enliven Therapeutics ELVN Insider Ownership

NASDAQ ELVN
$59.59 -0.06 (-0.10%)
As of: Sep 4, 2026 · 2:20 PM EDT

Insider Holdings by Owner

16.01Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
1.12%
+0.067% pp QoQ
Shares Held by Insiders
694.65K
filed for Sep 2026
+6.42% QoQ
Shares Outstanding
62.09Mn
62,093,795 shares
Direct Holdings
694.65K
Indirect: 0
Net Shares Traded (QoQ)
+41.88K
net buying in Sep 2026
Insiders Holding Shares
15
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

As of August 29, 2026, the three largest insider holders of ELVN are Rishi Gupta (Director, 8.66Mn shares), Rishi Gupta (Director, 7.66Mn shares), Partners Vi, Llc 5Am (TenPercentOwner, 4.31Mn shares).

Form 4 Holdings

Insiders Holding ELVN

Insiders 15
Shares held 16.01Mn
Of outstanding 25.78%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Rishi Gupta Director, TenPercentOwner 0 7,663,349 7,663,349 47.9% 20 May, 2024
2 Partners Vi, Llc 5Am TenPercentOwner 0 3,835,975 3,835,975 24.0% 16 Feb, 2024
3 Enterprise Associates 14, L.P. New TenPercentOwner 2,611,050 0 2,611,050 16.3% 07 Apr, 2022
4 Samuel Kintz President And Ceo 0 890,392 890,392 5.6% 19 Nov, 2025
5 Braden Michael Leonard TenPercentOwner 0 441,944 441,944 2.8% 05 Jan, 2023
6 Capital Lp Commodore TenPercentOwner 0 362,160 362,160 2.3% 27 Feb, 2023
7 Lori Anne Kunkel Director 41,884 0 41,884 0.3% 08 Jul, 2026
8 Benjamin Hohl Chief Financial Officer 40,036 0 40,036 0.3% 19 Aug, 2026
9 Helen Louise Collins Chief Medical Officer 25,000 0 25,000 0.2% 19 Aug, 2026
10 Rahul D. Ballal Chief Executive Officer 22,341 0 22,341 0.1% 10 Oct, 2024
11 Jake Bauer Director 21,843 0 21,843 0.1% 27 Feb, 2023
12 Anish Patel Chief Operating Officer 20,000 0 20,000 0.1% 17 Feb, 2026
13 Joseph P Lyssikatos Chief Scientific Officer 18,750 0 18,750 0.1% 17 Feb, 2026
14 Kenneth Attie Svp, Cmo 8,525 0 8,525 0.1% 01 Feb, 2022
15 Michael Gray Cfo Coo 6,903 0 6,903 0.0% 22 Feb, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

1,959 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
17 Aug, 2026 Helen Louise Collins Chief Medical Officer Acquired M 5,000 $2.48 $12.40K 30,000 Direct
17 Aug, 2026 Benjamin Hohl Chief Financial Officer Disposed S 4,630 $58.35 $270.17K 41,424 Direct
17 Aug, 2026 Benjamin Hohl Chief Financial Officer Disposed S 1,388 $59.35 $82.38K 40,036 Direct
17 Aug, 2026 Helen Louise Collins Chief Medical Officer Disposed S 3,900 $58.37 $227.65K 26,100 Direct
17 Aug, 2026 Helen Louise Collins Chief Medical Officer Disposed S 1,100 $59.35 $65.28K 25,000 Direct
17 Aug, 2026 Helen Louise Collins Chief Medical Officer Disposed M 5,000 $0.00 $0 111,268 Direct
04 Aug, 2026 Mika K Derynck Director Acquired M 87,373 $2.48 $216.69K 87,373 Direct
04 Aug, 2026 Mika K Derynck Director Acquired M 27,567 $25.28 $696.89K 114,940 Direct
04 Aug, 2026 Mika K Derynck Director Acquired M 23,364 $14.85 $346.96K 138,304 Direct
04 Aug, 2026 Mika K Derynck Director Acquired M 20,491 $22.47 $460.43K 158,795 Direct
04 Aug, 2026 Mika K Derynck Director Disposed S 158,795 $60.21 $9.56Mn 0 Direct
04 Aug, 2026 Mika K Derynck Director Disposed M 87,373 $0.00 $0 0 Direct
04 Aug, 2026 Mika K Derynck Director Disposed M 27,567 $0.00 $0 0 Direct
04 Aug, 2026 Mika K Derynck Director Disposed M 23,364 $0.00 $0 0 Direct
04 Aug, 2026 Mika K Derynck Director Disposed M 20,491 $0.00 $0 0 Direct
17 Jul, 2026 Benjamin Hohl Chief Financial Officer Acquired M 1,072 $2.48 $2.66K 52,072 Direct
17 Jul, 2026 Helen Louise Collins Chief Medical Officer Acquired M 5,000 $2.48 $12.40K 30,000 Direct
17 Jul, 2026 Helen Louise Collins Chief Medical Officer Disposed S 231 $50.05 $11.56K 29,769 Direct
17 Jul, 2026 Benjamin Hohl Chief Financial Officer Disposed S 324 $49.97 $16.19K 51,748 Direct
17 Jul, 2026 Benjamin Hohl Chief Financial Officer Disposed S 369 $51.48 $19.00K 51,379 Direct